Anthony J. Gill

82.0k total citations · 4 hit papers
535 papers, 16.9k citations indexed

About

Anthony J. Gill is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anthony J. Gill has authored 535 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Oncology, 189 papers in Surgery and 143 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anthony J. Gill's work include Pancreatic and Hepatic Oncology Research (112 papers), Thyroid Cancer Diagnosis and Treatment (59 papers) and Neuroendocrine Tumor Research Advances (58 papers). Anthony J. Gill is often cited by papers focused on Pancreatic and Hepatic Oncology Research (112 papers), Thyroid Cancer Diagnosis and Treatment (59 papers) and Neuroendocrine Tumor Research Advances (58 papers). Anthony J. Gill collaborates with scholars based in Australia, United States and United Kingdom. Anthony J. Gill's co-authors include Adele Clarkson, Roderick Clifton‐Bligh, Bruce G. Robinson, Angela Chou, Jaswinder S. Samra, Stan B. Sidhu, Leigh Delbridge, Loretta Sioson, Mark Sywak and Henry J. Dargie and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Anthony J. Gill

512 papers receiving 16.6k citations

Hit Papers

The 2022 World Health Org... 2022 2026 2023 2024 2022 2022 2022 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
    2022 399 citations Anthony J. Gill et al. profile →
  2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas
    2022 202 citations Anthony J. Gill et al. profile →
  3. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
    2022 140 citations Anthony J. Gill et al. profile →
  4. Overview of the 2022 WHO Classification of Parathyroid Tumors
    2022 133 citations Anthony J. Gill et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anthony J. Gill 5.7k 4.5k 4.4k 4.3k 3.6k 535 16.9k
Wolff Schmiegel 6.2k 1.1× 4.1k 0.9× 2.3k 0.5× 3.4k 0.8× 2.2k 0.6× 267 13.1k
David G. Pfister 8.9k 1.5× 2.8k 0.6× 7.2k 1.6× 5.9k 1.4× 1.9k 0.5× 328 19.3k
Manisha H. Shah 7.7k 1.3× 4.3k 0.9× 3.3k 0.8× 2.4k 0.6× 2.1k 0.6× 203 18.0k
Roger A’Hern 9.4k 1.6× 3.7k 0.8× 5.2k 1.2× 4.0k 0.9× 5.4k 1.5× 282 20.5k
Patrick Schöffski 9.6k 1.7× 4.8k 1.1× 9.5k 2.2× 3.2k 0.8× 2.2k 0.6× 510 19.4k
Andrew K. Stewart 7.6k 1.3× 1.9k 0.4× 4.6k 1.0× 5.8k 1.4× 1.8k 0.5× 166 15.1k
Vivek Subbiah 6.0k 1.0× 3.7k 0.8× 4.6k 1.1× 1.7k 0.4× 3.1k 0.9× 599 12.2k
Yoshitaka Fujii 8.3k 1.5× 7.7k 1.7× 9.1k 2.1× 2.0k 0.5× 4.0k 1.1× 439 19.9k
Electron Kebebew 4.3k 0.8× 3.8k 0.8× 1.4k 0.3× 7.7k 1.8× 4.1k 1.1× 378 19.1k
Andrew Arnold 10.4k 1.8× 7.3k 1.6× 3.0k 0.7× 1.3k 0.3× 2.2k 0.6× 225 19.0k

Countries citing papers authored by Anthony J. Gill

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Gill more than expected).

Fields of papers citing papers by Anthony J. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Gill. The network helps show where Anthony J. Gill may publish in the future.

Co-authorship network of co-authors of Anthony J. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Gill. A scholar is included among the top collaborators of Anthony J. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Gill. Anthony J. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nahm, Christopher B., John Turchini, H Rasmussen, et al.. (2025). FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. Cancer Medicine. 14(1). e70500–e70500.
2.
Leck, Lionel, et al.. (2025). Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Advanced Drug Delivery Reviews. 224. 115647–115647. 1 indexed citations
3.
4.
McGahan, William, Liu C, Anthony J. Gill, et al.. (2024). Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis on 68Ga-FAPI-PET/CT. Gastroenterology. 167(6). 1217–1220. 4 indexed citations
5.
Boehm, Emma, Anthony J. Gill, Roderick Clifton‐Bligh, & Richard W. Tothill. (2024). Recent progress in molecular classification of phaeochromocytoma and paraganglioma. Best Practice & Research Clinical Endocrinology & Metabolism. 38(6). 101939–101939. 2 indexed citations
6.
Gill, Anthony J., et al.. (2024). National screening for colorectal cancer is associated with stage shift to earlier diagnosis. ANZ Journal of Surgery. 94(7-8). 1279–1285. 1 indexed citations
7.
McKay, Matthew J., Mark P. Molloy, Anthony J. Gill, et al.. (2024). Novel serum protein biomarker panel for early diagnosis of pancreatic cancer. International Journal of Cancer. 155(2). 365–371. 5 indexed citations
8.
Pavlakis, Nick, Malinda Itchins, Jennifer Arena, et al.. (2023). The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer. Journal of Clinical Medicine. 12(5). 1989–1989. 24 indexed citations
9.
Sahni, Sumit, Christopher B. Nahm, Mahsa Ahadi, et al.. (2023). Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy. Cancer Medicine. 12(17). 18050–18061. 4 indexed citations
10.
Fuchs, Talia L., Catherine Luxford, Adele Clarkson, et al.. (2022). A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma. The American Journal of Surgical Pathology. 47(1). 25–36. 11 indexed citations
11.
Pai, Rish K., Ian Brown, Anthony J. Gill, et al.. (2022). Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study. Pathology. 54(3). 262–268. 6 indexed citations
12.
13.
Jha, Abhishek, Crystal Kamilaris, Anthony J. Gill, et al.. (2021). A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant. Endocrinology Diabetes and Metabolism Case Reports. 2021. 1 indexed citations
14.
Ahadi, Mahsa, Anthony J. Gill, Samar M. Said, et al.. (2020). SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. The American Journal of Surgical Pathology. 45(3). 414–420. 30 indexed citations
15.
Pinho, Andreia V., Lorraine A. Chantrill, David Herrmann, et al.. (2018). ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nature Communications. 9(1). 5083–5083. 40 indexed citations
16.
Yakirevich, Evgeny, Murray B. Resnick, Shamlal Mangray, et al.. (2016). Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Clinical Cancer Research. 22(15). 3831–3840. 88 indexed citations
17.
Pang, Tony, Anthony J. Gill, Ross C. Smith, et al.. (2016). A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. European Journal of Surgical Oncology. 42(10). 1576–1583. 36 indexed citations
18.
Wong, Matthew H., Aiqun Xue, Sohel M. Julovi, et al.. (2014). Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 20(15). 4047–4058. 33 indexed citations
19.
Dwight, Trisha, Diana E. Benn, Bruce G. Robinson, et al.. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. The Journal of Clinical Endocrinology & Metabolism. 98(6). E1103–E1108. 78 indexed citations
20.
Howell, Viive M., Anthony J. Gill, Adele Clarkson, et al.. (2008). Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 94(2). 434–441. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolff Schmiegel Breakdown of academic impact, for papers by David G. Pfister Breakdown of academic impact, for papers by Manisha H. Shah Breakdown of academic impact, for papers by Roger A’Hern Breakdown of academic impact, for papers by Patrick Schöffski Breakdown of academic impact, for papers by Andrew K. Stewart Breakdown of academic impact, for papers by Vivek Subbiah Breakdown of academic impact, for papers by Yoshitaka Fujii Breakdown of academic impact, for papers by Electron Kebebew Breakdown of academic impact, for papers by Andrew Arnold
Rankless by CCL
2026